CLINICAL_TRIALS
research
· 2025-06-04
Clinical Trial Update: A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice [NA]
Summary
A post-market registry is planned to assess the safety and performance of RefluxStop for gastroesophageal reflux disease in general hospital practice; recruitme…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Implantica CE Reflux Ltd. | Conditions: Gastroesophageal Reflux Disease | NA | Status: NOT_YET_RECRUITING